Search by Drug Name or NDC

    NDC 68308-0219-01 Esgic 325; 50; 40 mg/1; mg/1; mg/1 Details

    Esgic 325; 50; 40 mg/1; mg/1; mg/1

    Esgic is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayne Pharma Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL; CAFFEINE.

    Product Information

    NDC 68308-0219
    Product ID 68308-219_0e8524af-e875-ecb7-e063-6394a90aa259
    Associated GPIs 64991003100110
    GCN Sequence Number 004450
    GCN Sequence Number Description butalb/acetaminophen/caffeine CAPSULE 50-325-40 ORAL
    HIC3 H3L
    HIC3 Description ANALGESIC,NON-SALICYLATE,BARBITURATE,XANTHINE COMB
    GCN 72510
    HICL Sequence Number 001854
    HICL Sequence Number Description BUTALBITAL/ACETAMINOPHEN/CAFFEINE
    Brand/Generic Brand
    Proprietary Name Esgic
    Proprietary Name Suffix n/a
    Non-Proprietary Name butalbital, acetaminophen and caffeine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 325; 50; 40
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; BUTALBITAL; CAFFEINE
    Labeler Name Mayne Pharma Inc.
    Pharmaceutical Class Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA089007
    Listing Certified Through 2025-12-31

    Package

    NDC 68308-0219-01 (68308021901)

    NDC Package Code 68308-219-01
    Billing NDC 68308021901
    Package 100 CAPSULE in 1 BOTTLE, PLASTIC (68308-219-01)
    Marketing Start Date 2014-05-01
    NDC Exclude Flag N
    Pricing Information N/A
    << 68308-0152-60 68308-0220-01 >>

    Contents